Page 268 - Eshre Final Programme 2015
P. 268
P-641 Human preimplantation embryo pluripotency and DNA integrity are affected by induced retroelement expression.
P. Sakaloglou1, L. Lazaros2, C. Kitsou1, C. Kostoulas1, I. Bouba1, V. Maltabe3, P. Kouklis3, K. Zikopoulos2, T. Tzavaras3, I. Georgiou2
1University of Ioannina, Medical School Laboratory of Medical Genetics and Human Reproduction, Ioannina, Greece
2University of Ioannina, Medical School Department of Obstetrics and Gynecology Genetics and IVF Unit, Ioannina, Greece
3University of Ioannina, Medical School Department of General Biology, Ioannina, Greece
P-642 Chromosomal polymorphic variants increase the embryo aneuploidy rate in IVF cycles.
R. Morales Sabater1, B. Lledo1, J.A. Ortiz1, A. Rodriguez-Arnedo2, H. Blanca2, J. Llacer3, R. Bernabeu3
1Instituto Bernabeu Biotech, Molecular Biology, Alicante, Spain 2Instituto Bernabeu, Reproductive Biology, Alicante, Spain 3Instituto Bernabeu, Reproductive Medicine, Alicante, Spain
P-643 The inter-chromosomal effect, a reality: an example of a study on paternal meiosis
A. Hajlaoui1, M. Kammoun1, I. Zidi-Jrah1, S. Meddeb1, M. Fekih1, M. Ajina1, S. Ibala-Romdhane1, A. Saad1, S. Mougou-Zerelli1
1University Hospital Fhached, Department of Cytogenetic and Reproductive Biology, Sousse, Tunisia
P-644 Increased incidence of partial Y chromosome microdeletions in male newborns conceived by assisted reproductive technologies
P. Stanar1, R. Ng1, K. Louie1, V. Chow1, S. Ma1
1University of British Columbia, Obstetrics and Gynacology, Vancouver BC, Canada
P-645 The type of chromosomal alteration that is detected in aneuploid embryos is related to maternal age
J.A. Ortiz1, B. Lledó1, R. Morales1, I. Ochando2, J. Llácer3, R. Bernabeu3
1Instituto Bernabeu Biotech, Biología Molecular y Genética, Alicante, Spain 2Instituto Bernabeu, FIV, Alicante, Spain
3Instituto Bernabeu, Medicina Reproductiva, Alicante, Spain
P-646 Preimplantation genetic diagnosis (PGD) for inherited disorders using single nucleotide polymorphism (SNP) arrays: clinical outcomes of 100 cycles with transferable embryos A. Jordan1, R. Prates2, N. Goodall3, E. Armenti1, V. Tecson3, S. Munne3, M. Konstantinidis3, S. Jaroudi3, S. Jaroudi4
1Reprogenetics, Genetic Counseling, Livingston New Jersey, U.S.A. 2Reprogenetics, Molecular, Miami Florida, U.S.A.
3Reprogenetics, Molecular, Livingston New Jersey, U.S.A. 4Reprogenetics, Molecular, Al Ain, United Arab Emirates
268


































































































   266   267   268   269   270